Evidence map›Paper›PMID 33807093›Full record

ArticleCells2021

Deletion of the Actin-Associated Tropomyosin

Tamara Tomanić, Claire Martin, Holly Stefen, Esmeralda Parić, Peter Gunning, Thomas Fath

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Molecular cloning ofAnimal biotechnology · 2024
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tamara TomanićDementia Research Centre, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2052, Australia.ORCID 0000-0002-3266-1271
Claire MartinCellular and Genetic Medicine Unit, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.
Holly StefenDementia Research Centre, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2052, Australia.
Esmeralda ParićDementia Research Centre, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2052, Australia.
Peter GunningCellular and Genetic Medicine Unit, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.
Thomas FathDementia Research Centre, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2052, Australia.ORCID 0000-0002-6877-7567
Macquarie University · AUUNSW Sydney · AU

Funding

Australian Research Council DP180101473National Health and Medical Research Council APP200660
6 · The paper itself

Abstract

Tropomyosins (Tpms) have been described as master regulators of actin, with

Indexed as

Gene DeletionActin CytoskeletonActinsAmino Acid SequenceAnimalsAxonsCells, CulturedGrowth ConesHippocampusHumansMiceMice, Inbred C57BLMice, TransgenicNeuritesNeuronsNIH 3T3 CellsActinsProtein IsoformsTpm3 protein, mouseTropomyosinactin cytoskeletonneurite growthprotein segregation

Identifiers

PMID33807093
PMCPMC8005004
OpenAlexW3145124536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.